Objectives: Although hypertension and obesity are common comorbidities among patients with type 2 diabetes (T2D), their prevalence and burden has often not been explored outside the US. The objective of the current study was to assess the incremental effect of each comorbidity in isolation and in combination among T2D patients in Japan.
Introduction
► Recent estimates state approximately 13.2 million people in Japan may have diabetes (Ministry of Health, Labour, and Welfare, 2007) .
► Studies have found that both obesity and hypertension are highly prevalent comorbidities among those with type 2 diabetes (T2D) (Pi-Sunyer, 2009; Hogan et al., 2003) .
► Evidence suggests that the additional burden of these comorbidities can have a significant effect on the health outcomes of these patients (DiBonaventura, 2010).
► However, this research has primarily been conducted in the United States and it is unclear the extent to which the findings generalize to patients in Japan.
Objective
► The objective of the current study was to assess the incremental effect of hypertension and obesity in isolation and in combination among patients with T2D in Japan.
Methods

Data Source
► Data from the 2010 Japan National Health and Wellness Survey (NHWS) were used in the analysis.
► The NHWS is an Internet-based, self-reported survey administered to the adult population of Japan (N=25,000).
► A random stratified sampling framework was used to ensure the study respondents are identical to that of the total population in Japan (Liu et al., 2012) .
Sample
► Only respondents who reported that they had been diagnosed with T2D and who provided weight information were included in the analysis.
Measures
► Patients self-reported a diagnosis of T2D and hypertension (HTN). Patients also reported their height and weight which was converted to body mass index (BMI).
Obesity among the Japan population is defined by a BMI of 25 or greater.
► Age, gender, education, smoking status, exercise behavior, alcohol use, and the Charlson comorbidity index (based on self-reported physician diagnoses) were also assessed.
► Health outcomes included the SF-12v2 (mental and physical component summary scores and health state utilities) and healthcare resource utilization (number of physician visits, emergency room visits, and hospitalizations in the past 6 months).
Statistical Analyses
►Those with T2D+ HTN+obesity were compared with T2D+HTN only, T2D+obesity only, and T2D only patients with respect to demographics and health history variables.
►Regression models, controlling for age, gender, education, smoking status, exercise, alcohol use, and the Charlson comorbidity index, were used to examine differences on these groups with respect to health outcomes.
■ General linear models were used for health status ■ Generalized linear models were used for healthcare resource utilization due to pronounced variable skew.
Results
► Of the 942 patients who reported a diagnosis of T2D, most reported neither an obesity nor HTN comorbidity (n=402; 42.68%). 173 (18.37%) patients reported T2D+HTN, 171 (18.15%) reported T2D+obesity, and 196 (20.81%) reported T2D+HTN+obesity (see Figure 1) .
Results (continued)
► Patients were demographically similar across the T2D subgroups, though those with T2D and HTN only were older and less likely to be employed (see Table 1 ). 
Discussion
► Although approximately 40% of patients with T2D in Japan do not have concomitant HTN or obesity, those that do report a significant health status and direct cost burden.
► Further, the combined effect of both concomitant HTN and obesity was associated with incremental decrements in health status beyond either comorbidity alone.
► Improved management of these comorbidities could result in a substantial societal benefit. Figure 2 ). Differences on mental component summary scores were not significant. 
